0001781552-19-000003.txt : 20190712 0001781552-19-000003.hdr.sgml : 20190712 20190711213524 ACCESSION NUMBER: 0001781552-19-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190712 DATE AS OF CHANGE: 20190711 EFFECTIVENESS DATE: 20190712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nymbl Science, Inc. CENTRAL INDEX KEY: 0001781552 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-344117 FILM NUMBER: 19951971 BUSINESS ADDRESS: STREET 1: 3513BRIGHTON BLVD., SUITE 478 CITY: DENVER STATE: CO ZIP: 80216 BUSINESS PHONE: 650-233-4548 MAIL ADDRESS: STREET 1: 3513BRIGHTON BLVD., SUITE 478 CITY: DENVER STATE: CO ZIP: 80216 FORMER COMPANY: FORMER CONFORMED NAME: Nymbl Sciences, Inc. DATE OF NAME CHANGE: 20190703 D 1 primary_doc.xml X0708 D LIVE 0001781552 Nymbl Science, Inc. 3513 BRIGHTON BLVD., SUITE 478 DENVER CO COLORADO 80216 650-233-4548 DELAWARE Nymbl Sciences, Inc. Corporation true 2018 James Cook 3513 Brighton Blvd., Suite 478 Denver CO COLORADO 80216 Executive Officer Director Promoter Edward Likovich 3513 Brighton Blvd., Suite 478 Denver CO COLORADO 80216 Executive Officer Director Thomas Virden 3513 Brighton Blvd., Suite 478 Denver CO COLORADO 80216 Executive Officer Director Promoter Chris Saxman 3513 Brighton Blvd., Suite 478 Denver CO COLORADO 80216 Director Dr. Jean-Pierre Farcy 3513 Brighton Blvd., Suite 478 Denver CO COLORADO 80216 Promoter Carol Owens Jones 3513 Brighton Blvd., Suite 478 Denver CO COLORADO 80216 Promoter Other Technology Decline to Disclose 06b false 2019-06-27 false true false 10000 2675000 1970000 705000 Includes $695,000 of Series Seed-3 Preferred Stock, $505,000 of SAFEs converted into Series Seed-1 and $770,000 into Series Seed-2 Preferred Stock, and the underlying common stock. false 22 0 0 0 true false Nymbl Science, Inc. /s/ Stephen M. Wurzburg Stephen M. Wurzburg Assistant Secretary 2019-07-11